ReP USP - Resultado da busca

Artigo de periodico
P2X7 receptor isoform B is a key drug resistance mediator for neuroblastoma (2022)
Sampaio, Vanessa Fernandes Arnaud ; Bento, Carolina Adriane ; Glaser, Talita ; Adinolfi, Elena ; Ulrich, Henning ; Lameu, Claudiana
Fonte: Frontiers in Oncology. Unidade: IQ
Assuntos: RECEPTORES, NEUROBLASTOMA, RESISTÊNCIA MICROBIANA ÀS DROGAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SAMPAIO, Vanessa Fernandes Arnaud et al. P2X7 receptor isoform B is a key drug resistance mediator for neuroblastoma. Frontiers in Oncology, v. 12, p. 1-19 art. 966404, 2022Tradução . . Disponível em: https://doi.org/10.3389/fonc.2022.966404. Acesso em: 19 out. 2024.
APA
Sampaio, V. F. A., Bento, C. A., Glaser, T., Adinolfi, E., Ulrich, H., & Lameu, C. (2022). P2X7 receptor isoform B is a key drug resistance mediator for neuroblastoma. Frontiers in Oncology, 12, 1-19 art. 966404. doi:10.3389/fonc.2022.966404
NLM
Sampaio VFA, Bento CA, Glaser T, Adinolfi E, Ulrich H, Lameu C. P2X7 receptor isoform B is a key drug resistance mediator for neuroblastoma [Internet]. Frontiers in Oncology. 2022 ; 12 1-19 art. 966404.[citado 2024 out. 19 ] Available from: https://doi.org/10.3389/fonc.2022.966404
Vancouver
Sampaio VFA, Bento CA, Glaser T, Adinolfi E, Ulrich H, Lameu C. P2X7 receptor isoform B is a key drug resistance mediator for neuroblastoma [Internet]. Frontiers in Oncology. 2022 ; 12 1-19 art. 966404.[citado 2024 out. 19 ] Available from: https://doi.org/10.3389/fonc.2022.966404
Tese (Doutorado)
P2X7 receptor isoforms and neuroblastoma: the key role of P2X7B in drug resistance (2022)
Sampaio, Vanessa Fernandes Arnaud ; Lameu, Claudiana (Orientador)
Unidade: IQ
Assuntos: NEOPLASIAS, CÉLULAS-TRONCO, NEUROBLASTOMA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SAMPAIO, Vanessa Fernandes Arnaud. P2X7 receptor isoforms and neuroblastoma: the key role of P2X7B in drug resistance. 2022. Tese (Doutorado) – Universidade de São Paulo, São Paulo, 2022. Disponível em: https://www.teses.usp.br/teses/disponiveis/46/46131/tde-10082023-115821/. Acesso em: 19 out. 2024.
APA
Sampaio, V. F. A. (2022). P2X7 receptor isoforms and neuroblastoma: the key role of P2X7B in drug resistance (Tese (Doutorado). Universidade de São Paulo, São Paulo. Recuperado de https://www.teses.usp.br/teses/disponiveis/46/46131/tde-10082023-115821/
NLM
Sampaio VFA. P2X7 receptor isoforms and neuroblastoma: the key role of P2X7B in drug resistance [Internet]. 2022 ;[citado 2024 out. 19 ] Available from: https://www.teses.usp.br/teses/disponiveis/46/46131/tde-10082023-115821/
Vancouver
Sampaio VFA. P2X7 receptor isoforms and neuroblastoma: the key role of P2X7B in drug resistance [Internet]. 2022 ;[citado 2024 out. 19 ] Available from: https://www.teses.usp.br/teses/disponiveis/46/46131/tde-10082023-115821/
Artigo de periodico
Complex diseases demand novel treatment strategies: understanding drug combination (2022)
Mello, Renata Siqueira de ; Sampaio, Vanessa Fernandes Arnaud ; Maciel, Lucas Ferreira; Sá, Vanessa de ; Glaser, Talita ; Ulrich, Henning ; Lameu, Claudiana
Fonte: Drug Combination Therapy. Unidade: IQ
Assuntos: MEDICAMENTO, TERAPIA COMBINADA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MELLO, Renata Siqueira de et al. Complex diseases demand novel treatment strategies: understanding drug combination. Drug Combination Therapy, v. 4, n. 2, p. 1-12 art. 6, 2022Tradução . . Disponível em: https://doi.org/10.53388/DCT2022006. Acesso em: 19 out. 2024.
APA
Mello, R. S. de, Sampaio, V. F. A., Maciel, L. F., Sá, V. de, Glaser, T., Ulrich, H., & Lameu, C. (2022). Complex diseases demand novel treatment strategies: understanding drug combination. Drug Combination Therapy, 4( 2), 1-12 art. 6. doi:10.53388/DCT2022006
NLM
Mello RS de, Sampaio VFA, Maciel LF, Sá V de, Glaser T, Ulrich H, Lameu C. Complex diseases demand novel treatment strategies: understanding drug combination [Internet]. Drug Combination Therapy. 2022 ; 4( 2): 1-12 art. 6.[citado 2024 out. 19 ] Available from: https://doi.org/10.53388/DCT2022006
Vancouver
Mello RS de, Sampaio VFA, Maciel LF, Sá V de, Glaser T, Ulrich H, Lameu C. Complex diseases demand novel treatment strategies: understanding drug combination [Internet]. Drug Combination Therapy. 2022 ; 4( 2): 1-12 art. 6.[citado 2024 out. 19 ] Available from: https://doi.org/10.53388/DCT2022006
Artigo de periodico
Hyperactivation of P2X7 receptors as a culprit of COVID-19 neuropathology (2021)
Ribeiro, Deidiane Elisa ; Giacomelli, Ágatha Oliveira ; Glaser, Talita ; Sampaio, Vanessa Fernandes Arnaud ; Andrejew, Roberta ; Dieckmann, Luiz; Baranova, Juliana; Lameu, Claudiana ; Ratajczak, Mariusz Z; Ulrich, Henning
Fonte: Molecular Psychiatry. Unidade: IQ
Assuntos: COVID-19, RECEPTORES, SURTOS DE DOENÇAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RIBEIRO, Deidiane Elisa et al. Hyperactivation of P2X7 receptors as a culprit of COVID-19 neuropathology. Molecular Psychiatry, v. 26, p. 1044–1059, 2021Tradução . . Disponível em: https://doi.org/10.1038/s41380-020-00965-3. Acesso em: 19 out. 2024.
APA
Ribeiro, D. E., Giacomelli, Á. O., Glaser, T., Sampaio, V. F. A., Andrejew, R., Dieckmann, L., et al. (2021). Hyperactivation of P2X7 receptors as a culprit of COVID-19 neuropathology. Molecular Psychiatry, 26, 1044–1059. doi:10.1038/s41380-020-00965-3
NLM
Ribeiro DE, Giacomelli ÁO, Glaser T, Sampaio VFA, Andrejew R, Dieckmann L, Baranova J, Lameu C, Ratajczak MZ, Ulrich H. Hyperactivation of P2X7 receptors as a culprit of COVID-19 neuropathology [Internet]. Molecular Psychiatry. 2021 ; 26 1044–1059.[citado 2024 out. 19 ] Available from: https://doi.org/10.1038/s41380-020-00965-3
Vancouver
Ribeiro DE, Giacomelli ÁO, Glaser T, Sampaio VFA, Andrejew R, Dieckmann L, Baranova J, Lameu C, Ratajczak MZ, Ulrich H. Hyperactivation of P2X7 receptors as a culprit of COVID-19 neuropathology [Internet]. Molecular Psychiatry. 2021 ; 26 1044–1059.[citado 2024 out. 19 ] Available from: https://doi.org/10.1038/s41380-020-00965-3
Artigo de periodico
Cancer metabostemness and metabolic reprogramming via P2X7 receptor (2021)
Rabelo, Izadora Lorrany Alves; Sampaio, Vanessa Fernandes Arnaud ; Adinolfi, Elena ; Ulrich, Henning ; Lameu, Claudiana
Fonte: Cells. Unidade: IQ
Assuntos: CÉLULAS-TRONCO, NEOPLASIAS, RECEPTORES, METÁSTASE NEOPLÁSICA, METABOLISMO, QUIMIOTERAPIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RABELO, Izadora Lorrany Alves et al. Cancer metabostemness and metabolic reprogramming via P2X7 receptor. Cells, v. 10, p. 1-15 art. 1782, 2021Tradução . . Disponível em: https://doi.org/10.3390/cells10071782. Acesso em: 19 out. 2024.
APA
Rabelo, I. L. A., Sampaio, V. F. A., Adinolfi, E., Ulrich, H., & Lameu, C. (2021). Cancer metabostemness and metabolic reprogramming via P2X7 receptor. Cells, 10, 1-15 art. 1782. doi:10.3390/cells10071782
NLM
Rabelo ILA, Sampaio VFA, Adinolfi E, Ulrich H, Lameu C. Cancer metabostemness and metabolic reprogramming via P2X7 receptor [Internet]. Cells. 2021 ; 10 1-15 art. 1782.[citado 2024 out. 19 ] Available from: https://doi.org/10.3390/cells10071782
Vancouver
Rabelo ILA, Sampaio VFA, Adinolfi E, Ulrich H, Lameu C. Cancer metabostemness and metabolic reprogramming via P2X7 receptor [Internet]. Cells. 2021 ; 10 1-15 art. 1782.[citado 2024 out. 19 ] Available from: https://doi.org/10.3390/cells10071782
Artigo de periodico
Calcium signalling: a common target in neurological disorders and neurogenesis (2019)
Glaser, Talita ; Sampaio, Vanessa Fernandes Arnaud ; Lameu, Claudiana ; Ulrich, Henning
Fonte: Seminars in Cell and Developmental Biology. Unidade: IQ
Assuntos: DOENÇA DE ALZHEIMER, DOENÇA DE PARKINSON, CÉLULAS-TRONCO, RETÍCULO ENDOPLASMÁTICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GLASER, Talita et al. Calcium signalling: a common target in neurological disorders and neurogenesis. Seminars in Cell and Developmental Biology, v. 95, p. 25-33, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.semcdb.2018.12.002. Acesso em: 19 out. 2024.
APA
Glaser, T., Sampaio, V. F. A., Lameu, C., & Ulrich, H. (2019). Calcium signalling: a common target in neurological disorders and neurogenesis. Seminars in Cell and Developmental Biology, 95, 25-33. doi:10.1016/j.semcdb.2018.12.002
NLM
Glaser T, Sampaio VFA, Lameu C, Ulrich H. Calcium signalling: a common target in neurological disorders and neurogenesis [Internet]. Seminars in Cell and Developmental Biology. 2019 ; 95 25-33.[citado 2024 out. 19 ] Available from: https://doi.org/10.1016/j.semcdb.2018.12.002
Vancouver
Glaser T, Sampaio VFA, Lameu C, Ulrich H. Calcium signalling: a common target in neurological disorders and neurogenesis [Internet]. Seminars in Cell and Developmental Biology. 2019 ; 95 25-33.[citado 2024 out. 19 ] Available from: https://doi.org/10.1016/j.semcdb.2018.12.002

Unidades USP

ReP

Filtros

Autores

Autores USP

Assuntos

Título da fonte

Agência de fomento